Science Media Centre

Science Media Centre

Posted in In the News

Get RSS of
In the News

Cancer: the cost of a life – NZH special series

Posted in In the News on November 13th, 2015.

This week the New Zealand Herald has run an extensive five-part series – in print and online – delving deep into controversies in cancer testing and treatment and reporting on the moving stories of people afflicted with cancer.

NZH CancerThe ‘Cancer: the cost of a life’ series, authored by Herald health reporter Martin Johnston, is supported by insightful graphics and video interviews.

You can read all the articles in the series via the links below.

Monday: Breast Cancer || Tuesday: Bowel Cancer

Wednesday: Lung Cancer || Thursday: Melanoma

Friday: Prostate Cancer

Here is an excerpt from Monday’s introduction to the series:

The number of New Zealanders with cancer is rising steadily – as is the number of desperate patients who have resorted to asking strangers to help pay for expensive treatments that could save their lives.

This year, more than 20,000 people will have a cancer diagnosis registered, and about 9000 will die. For some, the cost of treatment that could increase their chance of survival can run into hundreds of thousands of dollars and is simply unaffordable.

The number of people turning to crowd-funding sites like Givealittle is increasing. This year alone, more than 650 appeals have been started by patients, or their friends and family, who have nowhere else to turn to when seeking non-taxpayer-funded medicines or other support.

Our cancer death rate is higher than the average for developed countries. If our rate matched Australia — where some drugs such as Keytruda are state-funded — about 700 fewer New Zealanders would die of cancer each year.

Today, the Herald begins a five-day cancer series. We look at controversies in cancer screening and treatment, we investigate high-cost cancer medicines not funded by the Government, and we interview a number of people with cancer, some whose outlook is grim, others who have experienced remarkable remissions.

Keep reading…

Print Friendly
Copyright 2016 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy